Steve Tutewohl Form 3/A Evolent Health / Steve Tutewohl ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Tutewohl Steve

(Last) (First) (Middle)

C/O EVOLENT HEALTH, INC.

800 NORTH GLEBE ROAD, SUITE 500

(Street)

ARLINGTON VA 22203

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
06/30/2020

3. Issuer Name and Ticker or Trading Symbol
Evolent Health, Inc. [ EVH ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chief Operating Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)
07/02/2020

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Class A Common Stock Option (right to buy)	(1)	02/01/2027	Class A Common Stock	15,319	18.25	D
Class A Common Stock Option (right to buy)	(2)	02/01/2028	Class A Common Stock	25,253	13.95	D
Class A Common Stock Option (right to buy)	(3)	03/01/2029	Class A Common Stock	21,552	13.29	D
Class A Common Stock Option (right to buy)	(4)	07/01/2029	Class A Common Stock	37,406	7.83	D

Explanation of Responses:

1. 15,319 options were granted on February 1, 2017 and vest and become exercisable ratably in four annual installments beginning on February 1, 2018. Prior to the date of the event requiring the filing of this Form 3, 11,490 of these options that remain outstanding had vested.

2. 25,253 options were granted on February 1, 2018 and vest and become exercisable ratably in four annual installments beginning on February 1, 2019. Prior to the date of the event requiring the filing of this Form 3, 12,627 of these options that remain outstanding had vested.

3. 21,552 options were granted on March 1, 2019 and vest and become exercisable ratably in four annual installments beginning on March 1, 2020. Prior to the date of the event requiring the filing of this Form 3, 5,388 of these options that remain outstanding had vested.

4. 37,406 options were granted on July 1, 2019 and vest and become exercisable ratably in four annual installments beginning on July 1, 2020. Prior to the date of the event requiring the filing of this Form 3, 0 of these options that remain outstanding had vested.

Remarks:

This Form 3 is filed to amend the Form 3 filed on July 2, 2020. The July 2, 2020 Form 3 inadvertently omitted certain derivative securities.

	/s/ Jonathan Weinberg, Attorney-in-fact	05/05/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.